Congratulations to Sabin Vaccine Institute on the launch of the Phase 2 clinical trial of their Sudan ebolavirus disease vaccine candidate! The Phase 2 trial for a Marburg vaccine is already underway. Sabin plans to hold similar-stage trials for the two vaccines in the U.S. next year. ReiThera is proud to serve as the manufacturing partner for the ChAd3-SUDV and ChAd3-MARV vaccines utilized in these trials. Read the full release: https://lnkd.in/eshgg28N #gmp #biotech #biotechnology #genetherapy #cellandgenetherapy #advancedtherapies
Very exciting indeed!
Great job REITHERA and Sabin Vaccine Institute!!!
Congradulations, SVI and Reithera team!
We're so grateful for your partnership in this work!